Covered recipient · General Payments record
ANGELA FAYE PERRY
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$8,221.27
- Reported across 119 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $808.76 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $629.96 | 19 |
| REVANCE THERAPEUTICS, INC. | $84.83 | 1 |
| Oyster Point Pharma, Inc. | $46.98 | 2 |
| Bausch & Lomb Americas Inc. | $24.93 | 1 |
| Tarsus Pharmaceuticals, Inc. | $22.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.83 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675300 | CMS |
| Amgen Inc. | $31.88 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675334 | CMS |
| Amgen Inc. | $30.00 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675336 | CMS |
| Amgen Inc. | $23.43 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675302 | CMS |
| Amgen Inc. | $19.64 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675304 | CMS |
| Amgen Inc. | $19.22 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675306 | CMS |
| Amgen Inc. | $146.01 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675314 | CMS |
| Amgen Inc. | $24.47 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675310 | CMS |
| Amgen Inc. | $7.27 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675308 | CMS |
| Amgen Inc. | $31.89 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675312 | CMS |
| Amgen Inc. | $125.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675320 | CMS |
| Amgen Inc. | $26.15 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675316 | CMS |
| Amgen Inc. | $22.05 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675318 | CMS |
| Amgen Inc. | $30.65 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675322 | CMS |
| Amgen Inc. | $7.01 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675324 | CMS |
| Amgen Inc. | $23.34 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675326 | CMS |
| Amgen Inc. | $7.57 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675328 | CMS |
| Amgen Inc. | $26.15 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675330 | CMS |
| Amgen Inc. | $6.40 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675332 | CMS |
| Bausch & Lomb Americas Inc. | $24.93 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140302414 | CMS |
| Oyster Point Pharma, Inc. | $25.82 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147408486 | CMS |
| Oyster Point Pharma, Inc. | $21.16 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147408508 | CMS |
| REVANCE THERAPEUTICS, INC. | $84.83 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147926745 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.06 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124280 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.